Pages that link to "Item:Q2684038"
From MaRDI portal
The following pages link to Modeling tumour heterogeneity of PD-L1 expression in tumour progression and adaptive therapy (Q2684038):
Displaying 4 items.
- A mechanistic systems pharmacology modeling platform to investigate the effect of PD-L1 expression heterogeneity and dynamics on the efficacy of PD-1 and PD-L1 blocking antibodies in cancer (Q2029579) (← links)
- Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer (Q2164665) (← links)
- Mathematical modeling of tumor immune interactions: the role of anti-FGFR and anti-PD-1 in the combination therapy (Q6597999) (← links)
- Mathematical modeling and quantitative analysis of phenotypic plasticity during tumor evolution based on single-cell data (Q6611879) (← links)
